Zhejiang Jingxin Pharmaceutical Co., Ltd.
Symbole: 002020.SZ
SHZ
12.29
CNYPrix du marché aujourd'hui
16.3059
Ratio P/E
-1.6917
Ratio PEG
10.58B
Cap MRK
- 0.02%
Rendement DIV
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020-SZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 7335.53 | 2019.9 | 1915.4 | 1977.2 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 1127.56 | 609.3 | 366.9 | 422.4 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 2431.47 | 664 | 570 | 586.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 2703.54 | 652.7 | 773.7 | 649.1 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 299.73 | 17.1 | 22.1 | 16.5 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 12770.27 | 3353.7 | 3281.2 | 3229.5 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 8656.05 | 2309.8 | 1632.1 | 1262.9 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 1393.94 | 348.5 | 348.5 | 257.9 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1617.31 | 401.3 | 418.6 | 137.7 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3011.25 | 749.7 | 767.1 | 395.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 2754.28 | 1471.1 | 218.9 | 119.5 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 297.88 | 81 | 75.1 | 62.5 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 4007.56 | 21.2 | 1388.1 | 1345.3 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 18727.02 | 4632.8 | 4081.4 | 3185.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 3316.2 | 610.8 | 719.1 | 435.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 1704.65 | 621.3 | 253.3 | 161.9 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 199.19 | 44.3 | 105.4 | 95 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 139.56 | 31.2 | 43 | 6.6 | |||||||||||||||||||||||
Deferred Revenue Non Current | 1091.72 | 268.8 | 270.6 | 128.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 254.92 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 805.52 | 789.3 | 761.9 | 4.7 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1227.33 | 102.8 | 375.2 | 192.6 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 139.56 | 31.2 | 43 | 6.5 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 9357.68 | 2177.6 | 2190.6 | 1577.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 3444.12 | 861 | 861 | 905.3 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 9981.01 | 2540.1 | 2228.8 | 1871.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 4893.06 | 388 | 336.1 | 285.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3443.45 | 1723.3 | 1720.2 | 1755.1 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 21761.63 | 5512.4 | 5146.1 | 4817.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 31497.29 | 7986.6 | 7362.6 | 6415.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 109.17 | 27.8 | 25.8 | 20.2 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 21870.8 | 5540.2 | 5172 | 4837.7 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 31497.29 | - | - | - | |||||||||||||||||||||||
Total Investments | 3881.85 | 2080.4 | 585.8 | 541.9 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 1844.21 | 652.5 | 296.3 | 168.5 | |||||||||||||||||||||||
balance-sheet.row.net-debt | -4363.76 | -758.2 | -1252.2 | -1386.3 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 638.91 | 618.9 | 667.8 | 614.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 10.99 | 221.5 | 166.9 | 143.6 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.8 | -12.2 | -5.8 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -488 | 12.2 | 5.8 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 29.56 | -45 | 21.3 | -391.7 | ||||||||||||||||||||||
cash-flows.row.account-receivables | -93.48 | -93.5 | -250.9 | -208.6 | ||||||||||||||||||||||
cash-flows.row.inventory | 123.04 | 123 | -103 | -147.8 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -74.6 | 387.4 | -41.8 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | -12.2 | 6.5 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 275.34 | 514.5 | -0.3 | -1.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 954.8 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 9.85 | 10.3 | 5.2 | 8.3 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -870.2 | -1175.2 | -1058 | -861.7 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1011.18 | 915 | 833.9 | 1407.9 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 311.97 | 0 | -3.2 | -5.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -189.34 | -769.4 | -737.7 | 144.7 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | -339.22 | -35 | -150 | -300.3 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | -258.11 | -258.3 | -258.6 | -232.2 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 593.64 | -4 | 220.5 | 653.3 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -180.91 | -245.6 | -188 | 120.8 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 5.78 | 2.7 | 14.9 | -3.8 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 684.27 | -77.8 | -55 | 626.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 5962.04 | 1410.6 | 1463.7 | 1512.8 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 5277.77 | 1488.5 | 1518.7 | 886 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 954.8 | 824.7 | 855.8 | 365 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | -339.78 | -519.5 | -515.6 | -404.4 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 615.02 | 305.2 | 340.2 | -39.4 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 4082.46 | 3952.1 | 3779.8 | 3336 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 2026.66 | 2048.3 | 1766.1 | 1472.8 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 2055.8 | 1903.8 | 2013.7 | 1863.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 410.79 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 78.1 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1442.43 | 1324.6 | 1354.4 | 1250.3 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3469.09 | 3372.9 | 3120.5 | 2723 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 43.91 | 60.3 | 65.6 | 48.1 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 790.89 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -21.94 | 6.4 | 135.7 | 99.8 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 77.27 | 134.9 | -6.3 | 1.5 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 6.56 | 7.3 | 6 | 3.7 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 82.38 | 221.5 | 182.9 | 170.6 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 740.39 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 658.01 | 579.2 | 756.6 | 693 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 735.28 | 714.1 | 750.3 | 694.5 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 90.4 | 84.6 | 82.5 | 79.8 | |||||||||||||||||||||||
income-statement-row.row.net-income | 638.91 | 618.9 | 662.3 | 612.5 |
Questions fréquemment posées
Quel est le total de Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) de l'actif total?
Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) Le total des actifs est 7986556907.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 2117348157.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.504.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 0.718.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.157.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.161.
Qu'est-ce que Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 618898033.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 652489982.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 1324586158.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 2069633166.000.